NAPE-PLD Polyclonal Antibody, PerCP-Cy5.5 Conjugated, PerCP/Cy5.5, Rabbit

Produktübersicht

• Artikelname: NAPE-PLD Polyclonal Antibody, PerCP-Cy5.5 Conjugated, PerCP/Cy5.5, Rabbit
• Artikelnummer: BSS-BS-19015R-PERCP-CY5.5
• Hersteller Artikelnummer: bs-19015R-PerCP-Cy5.5
• Alternativnummer: BSS-BS-19015R-PERCP-CY5.5-100
• Hersteller: Bioss
• Wirt: Rabbit
• Kategorie: Antikörper
• Applikation: IF, WB
• Spezies Reaktivität: Mouse
• Konjugation: PerCP/Cy5.5
• Alternative Synonym: C7orf18, DKFZp781D1098, FMP30, Mbldc1, N acyl phosphatidylethanolamine hydrolyzing phospholipase D, N acyl phosphatidylethanolamine phospholipase D, N-acyl phosphatidylethanolamine phospholipase D, N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D, NAPE hydrolyzing phospholipase D, NAPE-hydrolyzing phospholipase D, NAPE-PLD, NAPEP_HUMAN, NAPEPLD.

Produktbeschreibung

NAPEPLD is a phospholipase D type enzyme that catalyzes the release of N-acylethanolamine (NAE) from N-acyl-phosphatidylethanolamine (NAPE) in the second step of the biosynthesis of N-acylethanolamine (Okamoto et al., 2004 [PubMed 14634025]).[supplied by OMIM, Oct 2008]

Produkteigenschaften

• Klonalität: Polyclonal
• Konzentration: 1ug/ul
• NCBI: 222236
• UniProt: Q6IQ20
• Puffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
• Quelle: KLH conjugated synthetic peptide derived from human NAPE-PLD
• Target-Kategorie: NAPE-PLD

Anwendungsbeschreibung

• Application Verdünnung: WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)